SPX TECHNOLOGIES INC (SPXC)

US78473E1038 - Common Stock

121.52  +1.62 (+1.35%)

After market: 121.52 0 (0%)

Fundamental Rating

5

SPXC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 132 industry peers in the Machinery industry. SPXC has an average financial health and profitability rating. SPXC shows excellent growth, but is valued quite expensive already. These ratings would make SPXC suitable for growth investing!



6

1. Profitability

1.1 Basic Checks

In the past year SPXC was profitable.
SPXC had a positive operating cash flow in the past year.
Each year in the past 5 years SPXC has been profitable.
SPXC had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

SPXC's Return On Assets of 3.68% is in line compared to the rest of the industry. SPXC outperforms 50.39% of its industry peers.
Looking at the Return On Equity, with a value of 7.53%, SPXC is in line with its industry, outperforming 49.61% of the companies in the same industry.
SPXC has a Return On Invested Capital of 8.16%. This is in the better half of the industry: SPXC outperforms 61.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SPXC is significantly below the industry average of 10.72%.
The last Return On Invested Capital (8.16%) for SPXC is above the 3 year average (4.66%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.68%
ROE 7.53%
ROIC 8.16%
ROA(3y)6.63%
ROA(5y)5.49%
ROE(3y)15.37%
ROE(5y)15.14%
ROIC(3y)4.66%
ROIC(5y)4.94%

1.3 Margins

SPXC has a Profit Margin (5.16%) which is comparable to the rest of the industry.
SPXC's Profit Margin has been stable in the last couple of years.
SPXC has a Operating Margin of 12.79%. This is in the better half of the industry: SPXC outperforms 67.44% of its industry peers.
SPXC's Operating Margin has improved in the last couple of years.
SPXC has a better Gross Margin (38.48%) than 76.74% of its industry peers.
In the last couple of years the Gross Margin of SPXC has grown nicely.
Industry RankSector Rank
OM 12.79%
PM (TTM) 5.16%
GM 38.48%
OM growth 3Y13.64%
OM growth 5Y11.56%
PM growth 3Y-6.08%
PM growth 5Y-0.44%
GM growth 3Y7.81%
GM growth 5Y7.59%

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SPXC is destroying value.
The number of shares outstanding for SPXC has been increased compared to 1 year ago.
SPXC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SPXC has a worse debt to assets ratio.

2.2 Solvency

SPXC has an Altman-Z score of 3.90. This indicates that SPXC is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.90, SPXC is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
The Debt to FCF ratio of SPXC is 3.02, which is a good value as it means it would take SPXC, 3.02 years of fcf income to pay off all of its debts.
SPXC has a Debt to FCF ratio of 3.02. This is in the better half of the industry: SPXC outperforms 68.99% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that SPXC is not too dependend on debt financing.
SPXC has a Debt to Equity ratio (0.45) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 3.02
Altman-Z 3.9
ROIC/WACC0.89
WACC9.21%

2.3 Liquidity

SPXC has a Current Ratio of 1.77. This is a normal value and indicates that SPXC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.77, SPXC is doing worse than 64.34% of the companies in the same industry.
A Quick Ratio of 1.08 indicates that SPXC should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.08, SPXC perfoms like the industry average, outperforming 41.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.08

7

3. Growth

3.1 Past

SPXC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.16%, which is quite impressive.
The Earnings Per Share has been growing slightly by 1.19% on average over the past years.
Looking at the last year, SPXC shows a quite strong growth in Revenue. The Revenue has grown by 19.19% in the last year.
Measured over the past years, SPXC shows a small growth in Revenue. The Revenue has been growing by 2.50% on average per year.
EPS 1Y (TTM)39.16%
EPS 3Y-3.25%
EPS 5Y1.19%
EPS growth Q2Q6.84%
Revenue 1Y (TTM)19.19%
Revenue growth 3Y3.74%
Revenue growth 5Y2.5%
Revenue growth Q2Q9.34%

3.2 Future

Based on estimates for the next years, SPXC will show a very strong growth in Earnings Per Share. The EPS will grow by 23.84% on average per year.
SPXC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.67% yearly.
EPS Next Y10.66%
EPS Next 2Y28.22%
EPS Next 3Y23.84%
EPS Next 5YN/A
Revenue Next Year4.84%
Revenue Next 2Y16.37%
Revenue Next 3Y15.67%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.26 indicates a quite expensive valuation of SPXC.
Compared to the rest of the industry, the Price/Earnings ratio of SPXC is on the same level as its industry peers.
SPXC is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 24.84, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 31.65 indicates a quite expensive valuation of SPXC.
62.79% of the companies in the same industry are cheaper than SPXC, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SPXC to the average of the S&P500 Index (21.35), we can say SPXC is valued slightly more expensively.
Industry RankSector Rank
PE 28.26
Fwd PE 31.65

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SPXC is valued a bit more expensive than 67.44% of the companies in the same industry.
SPXC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 30.45
EV/EBITDA 21.2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SPXC does not grow enough to justify the current Price/Earnings ratio.
SPXC has a very decent profitability rating, which may justify a higher PE ratio.
SPXC's earnings are expected to grow with 23.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.65
PEG (5Y)23.81
EPS Next 2Y28.22%
EPS Next 3Y23.84%

0

5. Dividend

5.1 Amount

No dividends for SPXC!.
Industry RankSector Rank
Dividend Yield N/A

SPX TECHNOLOGIES INC

NYSE:SPXC (4/26/2024, 7:17:20 PM)

After market: 121.52 0 (0%)

121.52

+1.62 (+1.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.62B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 28.26
Fwd PE 31.65
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.65
PEG (5Y)23.81
Profitability
Industry RankSector Rank
ROA 3.68%
ROE 7.53%
ROCE
ROIC
ROICexc
ROICexgc
OM 12.79%
PM (TTM) 5.16%
GM 38.48%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.77
Quick Ratio 1.08
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)39.16%
EPS 3Y-3.25%
EPS 5Y
EPS growth Q2Q
EPS Next Y10.66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)19.19%
Revenue growth 3Y3.74%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y